Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23145 | 24006275 | Magn Reson Med | Max-IDEAL: a max-flow based approach for IDEAL water/fat separation. | 2013 | Details |
| A23146 | 24005104 | Nihon Shokakibyo Gakkai Zasshi | [A case of liver cirrhosis due to non-alcoholic steatohepatitis complicated by myotonic dystrophy]. | 2013 | Details |
| A23149 | 24004441 | Free Radic Res | Involvement of free radicals and oxidative stress in NAFLD/NASH. | 2013 | Details |
| A23150 | 24002947 | Hepatology | Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. | 2014 | Details |
| A23151 | 24002776 | Hepatology | Extrahepatic complications of nonalcoholic fatty liver disease. | 2014 | Details |
| A23152 | 24002036 | Endocrinology | Maternal hypoxia increases the susceptibility of adult rat male offspring to high-fat diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
| A23153 | 24000796 | Free Radic Res | Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease. | 2013 | Details |
| A23154 | 23999488 | Biochim Biophys Acta | A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease. | 2013 | Details |
| A23155 | 23998651 | Liver Int | Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. | 2013 | Details |
| A23156 | 23998390 | Liver Int | Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. | 2013 | Details |
| A23157 | 23997767 | Int J Endocrinol | Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). | 2013 | Details |
| A23158 | 23997501 | J Clin Exp Hepatol | Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults. | 2013 | Details |
| A23159 | 23997062 | Eur Respir Rev | Sleep apnoea and metabolic dysfunction. | 2013 | Details |
| A23160 | 23996808 | Hepatology | Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. | 2014 | Details |
| A23161 | 23996518 | Horm Metab Res | Olive oil attenuates the cholesterol-induced development of nonalcoholic steatohepatitis despite increased insulin resistance in a rodent model. | 2013 | Details |
| A23162 | 23994650 | Transl Res | The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes. | 2013 | Details |
| A23163 | 23994574 | Free Radic Biol Med | Free radical biology for medicine: learning from nonalcoholic fatty liver disease. | 2013 | Details |
| A23164 | 25755505 | J Clin Exp Hepatol | MicroRNAs in Liver Disease: Bench to Bedside. | 2013 | Details |
| A23165 | 25755498 | J Clin Exp Hepatol | Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study. | 2013 | Details |
| A23166 | 23991406 | Diabetes Metab J | The role of skeletal muscle in development of nonalcoholic Fatty liver disease. | 2013 | Details |
| A23167 | 23990360 | Diabetes | Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease. | 2013 | Details |
| A23168 | 23988487 | Biochem Pharmacol | Bile acid receptors in non-alcoholic fatty liver disease. | 2013 | Details |
| A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
| A23170 | 23985808 | Am J Clin Nutr | Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. | 2013 | Details |
| A23171 | 23985000 | Expert Rev Gastroenterol Hepatol | Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already? | 2013 | Details |
| A23172 | 23974690 | Indian J Dermatol Venereol Leprol | Comorbidities in psoriasis. | 2013 | Details |
| A23173 | 23983685 | Int J Endocrinol | Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease. | 2013 | Details |
| A23174 | 23983447 | World J Gastroenterol | Favorable effect of modest alcohol consumption to fatty liver disease. | 2013 | Details |
| A23175 | 23983438 | World J Gastroenterol | Prevalence and features of fatty liver detected by physical examination in Guangzhou. | 2013 | Details |
| A23176 | 23983432 | World J Gastroenterol | Investigation of genome instability in patients with non-alcoholic steatohepatitis. | 2013 | Details |
| A23178 | 23982157 | Am J Physiol Endocrinol Metab | Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice. | 2013 | Details |
| A23179 | 23981628 | Chin Med J (Engl) | Uncoupling protein and nonalcoholic fatty liver disease. | 2013 | Details |
| A23180 | 23981577 | Cancer Lett | Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. | 2013 | Details |
| A23181 | 23981342 | Cardiovasc Diabetol | Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. | 2013 | Details |
| A23182 | 23981121 | J Gastroenterol Hepatol | Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A23183 | 23980352 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease]. | 2013 | Details |
| A23184 | 23978719 | J Hepatol | Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. | 2013 | Details |
| A23185 | 23978414 | Food Chem Toxicol | Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. | 2013 | Details |
| A23186 | 23977033 | PLoS One | Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease. | 2013 | Details |
| A23187 | 23976771 | JPEN J Parenter Enteral Nutr | The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23188 | 23975682 | Cochrane Database Syst Rev | Herbal medicines for fatty liver diseases. | 2013 | Details |
| A23189 | 23975340 | Dig Dis Sci | Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats. | 2013 | Details |
| A23190 | 23975270 | J Gastroenterol | The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease. | 2013 | Details |
| A23191 | 23973932 | J Hepatol | Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23192 | 23973920 | Gastroenterology | Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. | 2013 | Details |
| A23194 | 23972952 | J Nutr Biochem | Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis. | 2013 | Details |
| A23195 | 23971751 | Expert Rev Clin Immunol | Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. | 2013 | Details |
| A23196 | 23970949 | Oxid Med Cell Longev | Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome. | 2013 | Details |
| A23197 | 23969900 | Int J Oncol | Non-B, non-C hepatocellular carcinoma (Review). | 2013 | Details |
| A23198 | 23967746 | Zhonghua Gan Zang Bing Za Zhi | [Construction of short hairpin RNA targeting aquaglyceroporin 9 and screening its effect on molecular mechanisms of nonalcoholic fatty liver disease using a cell model system]. | 2013 | Details |
| A23199 | 23966104 | Thromb Haemost | The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. | 2013 | Details |
| A23200 | 23965360 | Endocr J | Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress. | 2013 | Details |
| A23201 | 23964925 | Genet Test Mol Biomarkers | Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis. | 2013 | Details |
| A23202 | 23964070 | Am J Physiol Endocrinol Metab | Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. | 2013 | Details |
| A23203 | 23962548 | Clin Gastroenterol Hepatol | Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. | 2013 | Details |
| A23204 | 23961483 | Indian J Endocrinol Metab | Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? | 2013 | Details |
| A23205 | 23960084 | Mol Endocrinol | Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD. | 2013 | Details |
| A23206 | 23959503 | Hepatology | Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. | 2014 | Details |
| A23208 | 23958600 | Nat Rev Gastroenterol Hepatol | The Gordian Knot of dysbiosis, obesity and NAFLD. | 2013 | Details |
| A23209 | 23958599 | Nat Rev Gastroenterol Hepatol | From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. | 2013 | Details |
| A23211 | 23958268 | Atherosclerosis | Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. | 2013 | Details |
| A23212 | 23958203 | J Pharm Pharm Sci | Light-to-moderate ethanol feeding augments AMPK-α phosphorylation and attenuates SREBP-1 expression in the liver of rats. | 2013 | Details |
| A23214 | 23954219 | Gene | Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23215 | 23951308 | PLoS One | The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. | 2013 | Details |
| A23216 | 23951244 | PLoS One | Metformin protects rat hepatocytes against bile acid-induced apoptosis. | 2013 | Details |
| A23217 | 23951220 | PLoS One | Chronic ethanol consumption disrupts the core molecular clock and diurnal rhythms of metabolic genes in the liver without affecting the suprachiasmatic nucleus. | 2013 | Details |
| A23218 | 23948064 | Biochem Pharmacol | Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. | 2013 | Details |
| A23219 | 23947743 | Clin Sci (Lond) | Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study. | 2014 | Details |
| A23220 | 23945039 | Eur J Prev Cardiol | Gamma-glutamyltransferase, insulin resistance and cardiometabolic risk profile in a middle-aged African population. | 2013 | Details |
| A23221 | 23944954 | Liver Int | Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomes. | 2013 | Details |
| A23222 | 23942585 | Eur J Nutr | Dietary walnut oil modulates liver steatosis in the obese Zucker rat. | 2013 | Details |
| A23223 | 23941829 | Cancer Lett | NAFLD leads to liver cancer: do we have sufficient evidence? | 2013 | Details |
| A23224 | 23940514 | PLoS One | NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. | 2013 | Details |
| A23225 | 23940240 | Pediatrics | Ethnic differences in the link between insulin resistance and elevated ALT. | 2013 | Details |
| A23226 | 23940130 | J Clin Pathol | Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2013 | Details |
| A23228 | 23939604 | Am Fam Physician | Nonalcoholic fatty liver disease: diagnosis and management. | 2013 | Details |
| A23229 | 23938069 | J Psychosoc Nurs Ment Health Serv | A "glucose eater" drug as a therapeutic agent in psychiatry. | 2013 | Details |
| A23230 | 23935829 | PLoS One | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. | 2013 | Details |
| A23231 | 23935723 | Exp Ther Med | Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. | 2013 | Details |
| A23232 | 23935653 | Evid Based Complement Alternat Med | The Korean Mistletoe (Viscum album coloratum) Extract Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity. | 2013 | Details |
| A23233 | 23935128 | Eur J Endocrinol | Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. | 2013 | Details |
| A23234 | 23934335 | Obes Surg | Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery? | 2014 | Details |
| A23235 | 23933938 | Hepatogastroenterology | Long-term (>=2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis. | 2013 | Details |
| A23236 | 23933265 | J Hepatol | Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. | 2013 | Details |
| A23237 | 23932906 | Clin Gastroenterol Hepatol | The impact of network medicine in gastroenterology and hepatology. | 2013 | Details |
| A23238 | 23932529 | Psychosomatics | Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study. | 2013 | Details |
| A23239 | 23932277 | Ultrasound Med Biol | Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23240 | 23931760 | Cell Metab | DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. | 2013 | Details |
| A23241 | 23930163 | Int J Prev Med | Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial. | 2013 | Details |
| A23242 | 23930133 | Hepat Mon | The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial. | 2013 | Details |
| A23244 | 23929732 | Hepatology | Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. | 2014 | Details |
| A23245 | 23929677 | Hepatology | Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. | 2014 | Details |
| A23246 | 23929039 | Int J Cancer | Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. | 2013 | Details |
| A23247 | 23928404 | J Hepatol | Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. | 2013 | Details |
| A23248 | 23928114 | J Appl Physiol (1985) | Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. | 2013 | Details |
| A23249 | 23928105 | Metabolism | Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. | 2013 | Details |
| A23250 | 23927644 | Eur J Clin Invest | Intrahepatic cholestasis in common chronic liver diseases. | 2013 | Details |
| A23251 | 23924883 | Int J Environ Res Public Health | Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23252 | 23924495 | Hepatobiliary Pancreat Dis Int | Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. | 2013 | Details |
| A23253 | 23923372 | Trop Gastroenterol | Fibrosis in non-alcoholic fatty liver disease: correlation with simple blood indices and association with tumor necrosis factor-alpha polymorphisms. | 2013 | Details |